T1	Disorder 9 23	Rhabdomyolysis
N1 	Reference T1 UMLS:C0035410	Rhabdomyolysis
T2	Disorder 41 69	acute lymphoblastic leukemia
N2 	Reference T2 UMLS:C0023449	acute lymphoblastic leukemia
T3	Disorder 124 138	rhabdomyolysis
N3 	Reference T3 UMLS:C0035410	rhabdomyolysis
T4	Disorder 162 176	acute leukemia
N4 	Reference T4 UMLS:C0085669	acute leukemia
T6	Pharmacological_substance 430 450	cytosine arabinoside
N1000 	Reference T6 MeSH:D003561	cytosine arabinoside
T7	Pharmacological_substance 452 457	ARA-C
N1001 	Reference T7 MeSH:D003561	ARA-C
N1002 	Reference T7 MeSH:D003561	ARA-C
T9	Disorder 518 523	fever
N5 	Reference T9 UMLS:C0015967	fever
T10	Disorder 525 549	infectious complications
N6 	Reference T10 UMLS:C0275524	infectious complications
N7 	Reference T10 UMLS:C0275524	infectious complications
T11	Disorder 594 602	myalgias
N8 	Reference T11 UMLS:C0231528	myalgias
T13	Disorder 805 833	acute lymphoblastic leukemia
N9 	Reference T13 UMLS:C0023449	acute lymphoblastic leukemia
T14	Disorder 859 867	myalgias
N10 	Reference T14 UMLS:C0231528	myalgias
T21	Disorder 1230 1236	sepsis
N11 	Reference T21 UMLS:C0243026	sepsis
T22	Disorder 1261 1272	dehydration
N12 	Reference T22 UMLS:C0011175	dehydration
T23	Disorder 1300 1308	myalgias
N13 	Reference T23 UMLS:C0231528	myalgias
T24	Disorder 1419 1430	dehydration
N14 	Reference T24 UMLS:C0011175	dehydration
T25	Disorder 1438 1468	gastrointestinal complications
N15 	Reference T25 UMLS:C0161819	gastrointestinal complications
T26	Disorder 1470 1479	infection
N16 	Reference T26 UMLS:C0009450	infection
N17 	Reference T26 UMLS:C3714514	infection
T27	Pharmacological_substance 1504 1515	antibiotics
N1003 	Reference T27 MeSH:D000900	antibiotics
T17	Disorder 1217 1220	RML
N18 	Reference T17 UMLS:C0035410	RML
T18	Disorder 1327 1330	RML
N19 	Reference T18 UMLS:C0035410	RML
T20	Disorder 1071 1074	RML
N20 	Reference T20 UMLS:C0035410	RML
T29	Disorder 140 143	RML
N21 	Reference T29 UMLS:C0035410	RML
T30	Disorder 178 180	AL
N22 	Reference T30 UMLS:C0085669	AL
T31	Disorder 325 327	AL
N23 	Reference T31 UMLS:C0085669	AL
T32	Disorder 551 582	gastrointestinal tract symptoms
T33	Subject 27 35	patients
T34	Subject 148 156	patients
T35	Subject 300 319	Thirty-six patients
T37	Subject 763 799	five patients (4 males and 1 female)
T42	Subject 1012 1034	four of these patients
T43	Subject 1078 1086	all five
T44	Subject 501 505	five
T46	Pharmacological_substance 239 252	chemotherapy,
N1004 	Reference T46 MeSH:C403362	chemotherapy,
N1005 	Reference T46 MeSH:D004113	chemotherapy,
N1006 	Reference T46 MeSH:C057647	chemotherapy,
T47	Pharmacological_substance 385 397	chemotherapy
N1007 	Reference T47 MeSH:C403362	chemotherapy
N1008 	Reference T47 MeSH:D004113	chemotherapy
N1009 	Reference T47 MeSH:C057647	chemotherapy
T51	Pharmacological_substance 749 761	chemotherapy
N1010 	Reference T51 MeSH:C403362	chemotherapy
N1011 	Reference T51 MeSH:D004113	chemotherapy
N1012 	Reference T51 MeSH:C057647	chemotherapy
T52	Disorder 1088 1096	Myalgias
N24 	Reference T52 UMLS:C0231528	Myalgias
T53	Pharmacological_substance 1156 1168	chemotherapy
N1013 	Reference T53 MeSH:C403362	chemotherapy
N1014 	Reference T53 MeSH:D004113	chemotherapy
N1015 	Reference T53 MeSH:C057647	chemotherapy
T55	Pharmacological_substance 1395 1407	chemotherapy
N1016 	Reference T55 MeSH:C403362	chemotherapy
N1017 	Reference T55 MeSH:D004113	chemotherapy
N1018 	Reference T55 MeSH:C057647	chemotherapy
T5	Coreferring_mention 183 187	This
T15	Speculation_cue 1340 1348	probably
